表紙
市場調查報告書

微生物鑑定的全球市場:成長,趨勢,及預測(2019年∼2024年)

Microbial Identification Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 708597
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格
Back to Top
微生物鑑定的全球市場:成長,趨勢,及預測(2019年∼2024年) Microbial Identification Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年11月01日內容資訊: 英文 117 Pages
簡介

本報告提供全球微生物鑑定市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品&服務、方法、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
    • 感染疾病的發生率上升
    • 微生物鑑定的技術進步
    • 食品安全受到高度的關注
    • 為了促進微生物鑑定的政府配合措施及資金
  • 阻礙因素
    • 自動化微生物鑑定系統的高成本
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 產品、各類服務
    • 設備
    • 消耗品
    • 服務
  • 各方法
    • 表現型
    • 遺傳基因型
    • 蛋白質體學
  • 各用途
    • 診斷
    • 食品、飲料
    • 醫藥品
    • 化妝品、個人保健產品
    • 其他
  • 各終端用戶
    • 醫院,診療所,診斷研究所
    • 食品、飲料廠商
    • 製藥企業
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Becton, Dickinson and Company
    • Biolog, Inc.
    • BioMerieux SA
    • Bruker Corporation
    • Charles River Laboratories International, Inc.
    • Danaher Corporation
    • Eurofins Scientific SE
    • Merck Millipore (Merck KGaA)
    • 株式會社島津製作所
    • Thermo Fisher Scientific Inc.
    • VWR Corporation

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64219

Market Overview

Several technological advances using simple molecular methods have become available in recent years for microbial identification and show potential for cost-benefit, specifically, peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR such as GeneXpert assays. PNA-FISH has been the most extensively studied technology in terms of the collaboration between pharmacy and medical intervention. Multiplex and broad-range molecular diagnostics are capable of lowering the result-time and increased sensitivity compared to growth-based blood culture systems.

There are thousands of pathogens known to cause disease in humans, and standard PCR assays have been developed to detect the most commonly occurring pathogens. Pyrosequencing and multitarget PCRs are two very useful strategies currently in development for clinical laboratories. Additionally, these new broad-based techniques have merit, based on their ability to identify organisms difficult to culture or newly emerging strains, as well as their capacity to track disease transmission.

Therefore, the market for microbial identification is expected to increase over the forecast period due to advancements in microbial identification which are enabling lower costs, lower result time and greater efficiency.

Scope of the Report

Microbial identification can be defined as "microbial characterization by a limited spectrum of tests pre-chosen and appropriate to the problem being studied."Following is the scope of the studied market report:

Key Market Trends

Instruments Lead the Product & Service Segment of Microbial Identification Market

There have been major advances in the identification techniques of clinically significant microorganisms. The spectrum of the identifiable organism has steadily increased over the years to become more inclusive of various microorganism strains. These include methods of faster identification of isolated organisms with mass spectrometry (MS) in clinical specimens and simpler.

The instruments available in the current market include AXIMA Microorganism Identification System, (manufactured by Shimadzu) and MicroSEQ Microbial Identification System (manufactured by Thermo Fischer Scientific), among others.

The above mentioned commercial instruments for microbial identification are based on techniques of mass spectrometry (MS), polymerase chain reaction (PCR) and time-of-flight mass spectrometry (TOF-MS). These advanced microbial identification systems are however not available uniformly across the globe, instead, their use is highly concentrated in North America and Europe region. Such factors give high opportunities for growth over the forecast period.

North America Holds the Largest Share in the Market

Being technologically advanced, North America has a good hold on the latest technologies that come into the market. Also, there is a good presence of big players in the North America region which indicates the availability of products related to microbial identification. However, there are some products of microbial identification which are yet to be approved in the United States which is acting as a barrier to the growth of the market over there.

Competitive Landscape

The market studied is moderately competitive and there are global as well as local players that are actively present in the market. In terms of major players, few companies are currently playing good and hold a healthy share in the market. Eg. Thermofisher Scientific, BioMerieux SA, Beckman Coulter, Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market along with the local and smaller companies that hold substantial share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

TABLE OF CONTENTs

1. INTRODUCTION

  • 1.1. Study Deliverables
  • 1.2. Study Assumptions
  • 1.3. Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1. Market Overview
  • 4.2. Market Drivers
    • 4.2.1. Rising Incidence of Infectious Diseases
    • 4.2.2. Technological Advancements in Microbial Identification
    • 4.2.3. Increasing Food Safety Concerns
    • 4.2.4. Government Initiatives and Funding for Promoting Microbial Identification
  • 4.3. Market Restraints
    • 4.3.1. High Cost of Automated Microbial Identification Systems
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Threat of New Entrants
    • 4.4.2. Bargaining Power of Buyers/Consumers
    • 4.4.3. Bargaining Power of Suppliers
    • 4.4.4. Threat of Substitute Products
    • 4.4.5. Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1. By Products & Services
    • 5.1.1. Instruments
    • 5.1.2. Consumables
    • 5.1.3. Services
  • 5.2. By Method
    • 5.2.1. Phenotypic Methods
    • 5.2.2. Genotypic Methods
    • 5.2.3. Proteomics-Based Methods
  • 5.3. By Application
    • 5.3.1. Diagnostics
    • 5.3.2. Food & Beverage Testing
    • 5.3.3. Pharmaceuticals
    • 5.3.4. Cosmetics and Personal Care Products Testing
    • 5.3.5. Other Applications
  • 5.4. By End-User
    • 5.4.1. Hospitals, Clinics & Diagnostic Laboratories
    • 5.4.2. Food & Beverage Manufacturers
    • 5.4.3. Pharmaceutical Companies
    • 5.4.4. Other End Users
  • 5.5. Geography
    • 5.5.1. North America
      • 5.5.1.1. United States
      • 5.5.1.2. Canada
      • 5.5.1.3. Mexico
    • 5.5.2. Europe
      • 5.5.2.1. Germany
      • 5.5.2.2. United Kingdom
      • 5.5.2.3. France
      • 5.5.2.4. Italy
      • 5.5.2.5. Spain
      • 5.5.2.6. Rest of Europe
    • 5.5.3. Asia Pacific
      • 5.5.3.1. China
      • 5.5.3.2. Japan
      • 5.5.3.3. India
      • 5.5.3.4. Australia
      • 5.5.3.5. South Korea
      • 5.5.3.6. Rest of Asia-Pacific
    • 5.5.4. Middle East and Africa
      • 5.5.4.1. GCC
      • 5.5.4.2. South Africa
      • 5.5.4.3. Rest of Middle East and Africa
    • 5.5.5. South America
      • 5.5.5.1. Brazil
      • 5.5.5.2. Argentina
      • 5.5.5.3. Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1. Company Profiles
    • 6.1.1. Becton, Dickinson and Company
    • 6.1.2. Biolog, Inc.
    • 6.1.3. BioMerieux SA
    • 6.1.4. Bruker Corporation
    • 6.1.5. Charles River Laboratories International, Inc.
    • 6.1.6. Danaher Corporation
    • 6.1.7. Eurofins Scientific S.E.
    • 6.1.8. Merck Millipore (Merck KGaA)
    • 6.1.9. Shimadzu Corporation
    • 6.1.10. Thermo Fisher Scientific Inc.
    • 6.1.11. VWR Corporation

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top